Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review

Patients with oligometastatic (OM) non-small cell lung cancer (NSCLC) have favorable outcomes compared to patients presenting with diffuse metastatic disease. Recent randomized trials have demonstrated safety and efficacy signals for local ablative therapies with radiotherapy, surgery, or radiofrequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjong, Michael C., Louie, Alexander V., Iyengar, Puneeth, Solomon, Benjamin J., Palma, David A., Siva, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350079/
https://www.ncbi.nlm.nih.gov/pubmed/34430379
http://dx.doi.org/10.21037/tlcr-20-994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350079/
https://www.ncbi.nlm.nih.gov/pubmed/34430379
http://dx.doi.org/10.21037/tlcr-20-994

Ejemplares similares